Clinical Trials - Genitourinary

 

DISEASE SITE

TITLE

PHASE

CONTACT

LOCATION 

 Renal

 "NEXT: Subsequent Exposure to Tyrosine Kinase Inhibition (TKI) at Recurrence After Adjuvant Therapy in Renal Cell Carcinoma (RCC) (PrE0801)" 

 

Natasha Wilson, nwilson@mvcc.cc

 402-991-8070 x203

-------------------------------

  Kelly Madcharo – kmadcharo@lmep.com

 Missouri Valley Cancer Consortium, Omaha, NEl

Nebraska Cancer Research Center; Lincoln Medical Education Partnership Lincoln, NE

 

 

 Renal

 "A Randomized Phase II Study to Determine the Effect of 2 Different Doses of AVE0005 (VEGF Trap) in Patients with Metastatic Renal Cell Carcinoma (E4805)  *Suspended 3/27/12 – ARM A REOPENED TO ACCRUAL" 

 II

Natasha Wilson, nwilson@mvcc.cc

 402-991-8070 x203

------------------------

 Kelly Madcharo – kmadcharo@lmep.com 402-483-2827

Missouri Valley Cancer Consortium, Omaha, NE;  

Nebraska Cancer Research Center/ Lincoln Medical Education Partnership Lincoln, NE

 Renal

 "A Double Blind Phase II Study Comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine,
Cisplatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma  (E90601)" 

 II

Deborah Meyer, RN, BGS

 (402) 559-6941

dmeyerk@unmc.edu

------------------------------

Natasha Wilson, nwilson@mvcc.cc

 402-991-8070 x203

--------------------

 Marcia Grafe                    402-483-2827 mgrafe@lmep.com

--------------

Rebecca Hadenfeldt, RN, BSN

RHadenfeldt@sfmc-gi.org

P: 308-398-6783

F: 309-398-3219

--------

Good Samaritan – Michaela Sherbeck - michaelasherbeck@catholichealth.net

Nebraska Medical Center, Omaha, NE;  

Missouri Valley Cancer Consortium, Omaha, NE;

Nebraska Cancer Research Center/ Lincoln Medical Education Partnership Lincoln; NE

Saint Francis Cancer Treatment Center, Grand Island, NE; Good Samaritan Cancer Center, Kearney, NE.

 Renal

 ARENO321, Treatment of High Risk Renal Tumors (CHMC IRB#487-0706/UNMC 035-10)

 

 Deborah Meyer, RN, BGS

 (402) 559-6941

dmeyerk@unmc.edu

Or Tamra Olson

 The Nebraska Medical Center, Omaha NE

 Renal

A Randomized, Double-Blind, Placebo-Controlled Phase III Study to Evaluate the Efficacy and Safety of Pazopanib as Adjuvant Therapy for Subjects with Localized or Locally Advanced RCC Following Nephrectomy

 III

 Deborah Meyer, RN, BGS

 (402) 559-6941

dmeyerk@unmc.edu

Or Terry Burke

 The Nebraska Medical Center, Omaha NE

Nebraska Oncology Society
c/o Nebraska Medical Association
Sarah Dunbar
Executive Director
233 South 13th Street Suite 1200
Lincoln, NE 68508
sarahd@nebmed.org (email)
402-474-4472 (phone)
402-474-2198 (fax)

Powered by Wild Apricot Membership Software